Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Cefrous I.5 Injection:
Cefrous I.5 Injection is a potent antibiotic formulation that combines Cefoperazone, a third-generation cephalosporin, with Sulbactam, a beta-lactamase inhibitor. This combination provides enhanced antibacterial activity, making it an effective choice for treating various bacterial infections.
Uses of Cefrous I.5 Injection:
Cefrous I.5 Injection is used in the treatment of:
Severe Bacterial Infections: Effective against a broad range of infections including respiratory tract infections, urinary tract infections, intra-abdominal infections, and skin and soft tissue infections.
Hospital-Acquired Infections: Provides effective treatment for infections acquired in a hospital setting, particularly those caused by beta-lactamase producing bacteria.
Benefits of Cefrous I.5 Injection:
Cefrous I.5 Injection offers significant benefits by combining the antibacterial efficacy of Cefoperazone with the beta-lactamase inhibiting action of Sulbactam. This dual-action approach enhances the effectiveness of the antibiotic therapy, ensuring comprehensive treatment of severe and resistant bacterial infections.
Mechanism of Action of Cefrous I.5 Injection:
Cefoperazone: A broad-spectrum cephalosporin antibiotic that inhibits bacterial cell wall synthesis, leading to bacterial cell death. It is effective against a wide variety of Gram-positive and Gram-negative bacteria.
Sulbactam: A beta-lactamase inhibitor that prevents the breakdown of beta-lactam antibiotics by beta-lactamase enzymes, thereby enhancing the efficacy of Cefoperazone against resistant bacteria.
Consult your healthcare provider to determine if Cefrous I.5 Injection is the appropriate treatment for managing your bacterial infection.
Beside this well also export in other countries